<a href="https://laohu8.com/S/INBS">Intelligent Bio Solutions</a> Faces Nasdaq Delisting Risk Over Sub-$1 Share Price
Intelligent Bio Solutions Inc. has received a deficiency letter from the Nasdaq Listing Qualifications Department, notifying the company that its common stock has traded below the $1.00 per share minimum bid price required for continued listing on the Nasdaq Capital Market. The company now has 180 calendar days, until June 15, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. To address the issue, Intelligent Bio Solutions implemented a 1-for-10 reverse stock split, effective December 15, 2025. If compliance is not achieved within the initial period, the company may qualify for an additional 180-day extension, but failure to meet requirements could result in delisting from Nasdaq.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-028003), on December 16, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。